Atrovent MDI

Generic Name: Ipratropium bromide
Product Name: Atrovent MDI

Indication

• Used for severe acute asthma
• Used for maintenance treatment in COPD and severe asthma
• Used as alternative to or in combination with beta 2 agonists in COPD

Action

Promote widening of airway diameter.

Dose advice

Adult:

• MDI: 40 mcg, repeat 3-4 times daily as necessary; up to 80mcg 3-4 times daily may be needed.
• Neb: 250-500mcg up to 3-4 times daily (dilute solution for nebulisation with 0.9% sodium chloride solution)

Child:

• MDI (child<6years): 20mcg, 3 times daily.
• MDI (child 6-12 years): 20-40 mcg, 3-4 times daily as necessary.
• Neb: 250mcg up to 3 times daily (dilute solution for nebulisation with 0.9% sodium chloride solution)

Schedule

S4

Common side effects

• Dry mouth.
• Throat irritation.

Uncommon side effects

• Urinary retention (there is a risk of aggravation of symptoms in patients with prostatic hypertrophy)
• Acute angle closure glaucoma (there is a risk of aggravation of symptoms in patients with coexisting glaucoma)
• Constipation
• Allergic reactions
• Ipratropium MDI should not be used by patients with allergy to soya lecithin or related food products such as soya bean and peanuts.

For further information talk to your doctor.